Answers are grounded in this paper and cite their sources.
For many years, Therapeutic Guidelines: Antibiotic has recommended the use of gentamicin for therapy of serious infections possibly caused by Gram-negative organisms. This is because of its rapid bactericidal activity and comparatively low levels of resistance in most community-and hospital-associated Gram-negative pathogens. These properties make it a very
No takes yet. Share an insight, caveat, or question.
Moulds et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: